Development of complement C5aR1 antagonists for the treatment of motor neuron disease (2016–2017)
- Grant type:
- UQ Collaboration and Industry Engagement Fund - FirstLink
- Researchers:
-
-
Associate Professor
School of Biomedical SciencesFaculty of Medicine -
NHMRC Professorial Fellow
School of Biomedical SciencesFaculty of Medicine
-
- Funded by:
- The University of Queensland
